Insider Transactions in Q4 2020 at Amag Pharmaceuticals, Inc. (AMAG)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2020
|
Paul R. Fonteyne Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,676
-100.0%
|
-
|
|
Nov 16
2020
|
Anthony Casciano Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
76,349
-100.0%
|
-
|
|
Nov 16
2020
|
John A. Fallon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,362
-100.0%
|
-
|
|
Nov 16
2020
|
Brian Piekos Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,538
-100.0%
|
-
|
|
Nov 16
2020
|
Kathrine O'Brien Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,949
-100.0%
|
-
|
|
Nov 16
2020
|
Gino Santini Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
41,473
-100.0%
|
-
|
|
Nov 16
2020
|
Joseph Vittiglio Chief Business Officer, GC |
SELL
Sale (or disposition) back to the issuer
|
Direct |
92,244
-100.0%
|
-
|
|
Nov 16
2020
|
James R Sulat Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,090
-100.0%
|
-
|
|
Nov 16
2020
|
Kelly Schick Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,155
-100.0%
|
-
|
|
Nov 16
2020
|
Caligan Partners LP > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,499,428
-100.0%
|
-
|
|
Nov 16
2020
|
David Edward Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,499,428
-100.0%
|
-
|
|
Nov 16
2020
|
David Edward Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,676
-100.0%
|
-
|
|
Nov 16
2020
|
Anne M. Phillips Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,949
-100.0%
|
-
|
|
Nov 16
2020
|
Davey Scoon Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,898
-100.0%
|
-
|
|
Oct 01
2020
|
Camber Capital Management LP |
SELL
Open market or private sale
|
Indirect |
4,390,000
-100.0%
|
$57,070,000
$13.57 P/Share
|